Abstract
The remarkable growth in the popularity of mendelian randomization (MR) studies—analyses using genetic polymorphisms as instrumental variables (IVs)—reflects both the importance of the causal inference problems addressed by MR and the potential power of the approach. 1 Although IV analysis is a well-established econometric tool, applications in health research using genetic information as IVs present novel challenges and opportunities. Papers such as that of Au Yeung et al., providing evidence on the characteristics of a proposed genetic IV for a specific phenotype-outcome association, 2 are important because they help establish a foundation of evidence relevant for many future MR studies. In this commentary, we discuss the value of integrating evidence from external sources, such as the Au Yeung et al. results in MR studies, with specific focus on using separate-sample IV (SSIV, sometimes called split-sample IV) in data from case-control studies.

This publication has 13 references indexed in Scilit: